Revision: Jan. 21, 2010, midnight
HB 111 – FINAL VERSION
HOUSE BILL 111
This bill establishes a commission to study the elimination of cervical cancer in the state of New Hampshire.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [
in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Five
AN ACT establishing a commission to study the elimination of cervical cancer in the state of New Hampshire.
Be it Enacted by the Senate and House of Representatives in General Court convened:
18:1 Commission Established. There is established a commission to study the elimination of cervical cancer in New Hampshire.
18:2 Membership and Compensation.
I. The members of the commission shall be as follows:
(a) Five members of the house of representatives, appointed by the speaker of the house.
(b) Two members of the senate, appointed by the president of the senate.
(c) One representative of the American Cancer Society, appointed by such society.
(d) One representative of a woman’s health organization, appointed by the governor.
(e) The commissioner of insurance, or designee.
(f) A gynecologist licensed in New Hampshire, appointed by the governor.
(g) The state epidemiologist, or designee.
(h) Two public members, appointed by the governor.
(i) A licensed pediatrician, appointed by the New Hampshire Medical Society.
(j) A licensed family physician, appointed by the New Hampshire Medical Society.
(k) A licensed registered nurse, appointed by the New Hampshire Nurses Association.
II. Legislative members of the commission shall receive mileage at the legislative rate when attending to the duties of the commission.
18:3 Duties. The commission’s study shall include, but not be limited to the following:
I. A statistical and qualitative examination of the prevalence and burden of cervical cancer.
II. How to raise public awareness on the causes and capture of cervical cancer, personal risk factors, value of prevention, early detection, options for testing, treatment costs, new technology, medical care reimbursement, and physician education.
III. Identifying priority strategies, new technologies, or newly introduced vaccines which are effective in preventing and controlling the risk of cervical cancer.
IV. Identifying and examining the limitations of existing laws, regulation, programs, and services with regard to coverage and awareness issues for cervical cancer.
V. Receiving and considering reports and testimony from individuals, local health departments, community-based organizations, voluntary health organizations, and other public and private organizations statewide to learn more about their contributions to cervical cancer diagnosis, prevention, and treatment and more about their ideas for improving cervical cancer prevention, diagnosis, and treatment in the state of New Hampshire.
VI. Developing a statewide comprehensive cervical cancer prevention plan and strategies for implementing and promoting the plan.
18:4 Chairperson; Quorum. The members of the study commission shall elect a chairperson from among the members. The first meeting of the commission shall be called by the first-named house member. The first meeting of the commission shall be held within 45 days of the effective date of this section. Seven members of the commission shall constitute a quorum.
18:5 Report. The commission shall report its findings and any recommendations for proposed legislation to the speaker of the house of representatives, the senate president, the house clerk, the senate clerk, the governor, and the state library on or before November 1, 2005.
18:6 Effective Date. This act shall take effect upon its passage.
(Approved: May 10, 2005)
(Effective Date: May 10, 2005)None